HRP20230067T1 - Ligand gaba receptora - Google Patents

Ligand gaba receptora Download PDF

Info

Publication number
HRP20230067T1
HRP20230067T1 HRP20230067TT HRP20230067T HRP20230067T1 HR P20230067 T1 HRP20230067 T1 HR P20230067T1 HR P20230067T T HRP20230067T T HR P20230067TT HR P20230067 T HRP20230067 T HR P20230067T HR P20230067 T1 HRP20230067 T1 HR P20230067T1
Authority
HR
Croatia
Prior art keywords
compound
use according
gaba
itching
receptor ligand
Prior art date
Application number
HRP20230067TT
Other languages
English (en)
Croatian (hr)
Inventor
Janus S. Larsen
Dipak AMRUTKAR
Thomas Amos JACOBSEN
Tino Dyhring
Karin Sandager Nielsen
Original Assignee
Saniona A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saniona A/S filed Critical Saniona A/S
Publication of HRP20230067T1 publication Critical patent/HRP20230067T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20230067TT 2018-09-13 2019-09-13 Ligand gaba receptora HRP20230067T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18194297 2018-09-13
PCT/EP2019/074465 WO2020053377A1 (en) 2018-09-13 2019-09-13 A gabaa receptor ligand
EP19765747.1A EP3849976B1 (en) 2018-09-13 2019-09-13 A gaba a receptor ligand

Publications (1)

Publication Number Publication Date
HRP20230067T1 true HRP20230067T1 (hr) 2023-03-17

Family

ID=63579205

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20230067TT HRP20230067T1 (hr) 2018-09-13 2019-09-13 Ligand gaba receptora

Country Status (24)

Country Link
US (1) US11396510B2 (cg-RX-API-DMAC7.html)
EP (1) EP3849976B1 (cg-RX-API-DMAC7.html)
JP (1) JP7353663B2 (cg-RX-API-DMAC7.html)
KR (1) KR102712565B1 (cg-RX-API-DMAC7.html)
CN (1) CN112714765B (cg-RX-API-DMAC7.html)
AU (1) AU2019338236B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021004661A2 (cg-RX-API-DMAC7.html)
CA (1) CA3110283A1 (cg-RX-API-DMAC7.html)
DK (1) DK3849976T3 (cg-RX-API-DMAC7.html)
EA (1) EA202190717A1 (cg-RX-API-DMAC7.html)
ES (1) ES2935705T3 (cg-RX-API-DMAC7.html)
FI (1) FI3849976T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20230067T1 (cg-RX-API-DMAC7.html)
HU (1) HUE060943T2 (cg-RX-API-DMAC7.html)
IL (1) IL281335B2 (cg-RX-API-DMAC7.html)
LT (1) LT3849976T (cg-RX-API-DMAC7.html)
MX (1) MX2021003010A (cg-RX-API-DMAC7.html)
PH (1) PH12021550299A1 (cg-RX-API-DMAC7.html)
PL (1) PL3849976T3 (cg-RX-API-DMAC7.html)
PT (1) PT3849976T (cg-RX-API-DMAC7.html)
SG (1) SG11202101360VA (cg-RX-API-DMAC7.html)
SI (1) SI3849976T1 (cg-RX-API-DMAC7.html)
WO (1) WO2020053377A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202100976B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240197733A1 (en) 2021-04-16 2024-06-20 Saniona A/S A gaba receptor modulator for use in the treatment of pain
EP4777104A1 (en) * 2023-09-15 2026-07-22 Saniona A/S A gaba receptor modulator for treating disorders associated with sleep spindle deficits
EP4777103A1 (en) * 2023-09-15 2026-07-22 Saniona A/S A gaba receptor modulator for use in the treatment of absence seizures
WO2026109691A1 (en) * 2024-11-22 2026-05-28 Saniona A/S A gaba receptor modulator for use in the treatment of tremor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675484B2 (en) 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
GB9702524D0 (en) 1997-02-07 1997-03-26 Merck Sharp & Dohme Therapeutic agents
GB9813576D0 (en) * 1998-06-24 1998-08-19 Merck Sharp & Dohme Therapeutic agents
JP2002535407A (ja) * 1999-01-27 2002-10-22 メルク シャープ エンド ドーム リミテッド Gaba受容体のリガンドとしてのトリアゾロピリダジン誘導体
GB9921150D0 (en) 1999-09-07 1999-11-10 Merck Sharp & Dohme Therapeutic agents
GB0208394D0 (en) * 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic agents
GB0208392D0 (en) * 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic compounds
GB0212048D0 (en) 2002-05-24 2002-07-03 Merck Sharp & Dohme Therapeutic agents
MXPA05010449A (es) 2003-04-03 2006-05-31 Neurosearch As Derivados del bencimidazol y su uso para modular el complejo del receptor de gabaa.
TWI391381B (zh) * 2006-03-24 2013-04-01 Neurosearch As 新穎的苯并咪唑衍生物、含有其之醫藥組成物、及其於製造藥物之用途
TW201029986A (en) 2008-11-14 2010-08-16 Neurosearch As Novel compounds
BR112018015386A2 (pt) 2016-01-27 2019-03-19 Universität Zürich uso de moduladores de receptor gabaa para tratamento de prurido

Also Published As

Publication number Publication date
LT3849976T (lt) 2023-02-10
EP3849976A1 (en) 2021-07-21
PT3849976T (pt) 2023-01-13
US11396510B2 (en) 2022-07-26
HUE060943T2 (hu) 2023-04-28
EA202190717A1 (ru) 2021-09-22
DK3849976T3 (da) 2023-01-23
FI3849976T3 (fi) 2023-02-19
WO2020053377A1 (en) 2020-03-19
CA3110283A1 (en) 2020-03-19
PL3849976T3 (pl) 2023-02-27
IL281335A (en) 2021-04-29
CN112714765A (zh) 2021-04-27
MX2021003010A (es) 2021-05-27
BR112021004661A2 (pt) 2021-06-01
KR102712565B1 (ko) 2024-10-02
CN112714765B (zh) 2023-06-30
SG11202101360VA (en) 2021-03-30
IL281335B1 (en) 2024-03-01
ZA202100976B (en) 2022-08-31
JP2022500445A (ja) 2022-01-04
US20210332042A1 (en) 2021-10-28
PH12021550299A1 (en) 2021-10-25
ES2935705T3 (es) 2023-03-09
IL281335B2 (en) 2024-07-01
AU2019338236B2 (en) 2025-01-09
SI3849976T1 (sl) 2023-03-31
JP7353663B2 (ja) 2023-10-02
EP3849976B1 (en) 2022-10-26
KR20210061338A (ko) 2021-05-27
AU2019338236A1 (en) 2021-05-20

Similar Documents

Publication Publication Date Title
HRP20210928T1 (hr) Soli ili ko-kristali 3- (3-dimetilamino-1-etil-2-metil-propil)-fenola
HRP20221294T1 (hr) Neuroaktivni steroidi, njihovi pripravci i uporabe
EA201792559A1 (ru) Фармацевтические композиции для местного применения
HRP20200648T1 (hr) Derivati sulfamoilpirolamida i njihova uporaba kao lijekova za liječenje hepatitisa b
HRP20230274T1 (hr) Kemijski spojevi
HRP20231018T1 (hr) Terapeutski spojevi korisni za profilaktičko ili terapijsko liječenje hiv virusne infekcije
HRP20171512T1 (hr) Derivati betulina
HRP20210351T1 (hr) Spojevi prostaciklina
HRP20211032T1 (hr) Postupci za uporabu agonista fxr
HRP20191285T1 (hr) Predlijekovi karbidopa i l-dopa te njihova uporaba za liječenje parkinsonove bolesti
RU2016105581A (ru) Способ лечения острого, хронического и подострого кашля и непреодолимого желания откашляться
ME02910B (me) Spojevi tetrahidropirolotiazina
HRP20220759T1 (hr) Pripravci i postupci koji ih koriste za liječenje neurodegenerativne i mitohondrijske bolesti
HRP20140011T1 (hr) Derivati oksazina i njihova uporaba u lijeäśenju neuroloških poremeä†aja
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
HRP20220683T1 (hr) Liječenje parkinsonove bolesti
HRP20250885T1 (hr) Spojevi kondenziranog tricikličkog piridazinona korisni za liječenje ortomiksovirusnih infekcija
HRP20151327T1 (hr) Farmaceutska kombinacija za lijeäśenje boli
HRP20171515T1 (hr) Spojevi fenoksietilpiperidina
HRP20230935T1 (hr) Postupci za liječenje i profilaksu hiv-a i aids-a
FI3849976T3 (fi) Gaba a -reseptorin ligandi
JP2022500445A5 (cg-RX-API-DMAC7.html)
JP2019218379A5 (cg-RX-API-DMAC7.html)
CN111526878A (zh) 含三萜类化合物的药物组合物及其用途
HRP20240605T1 (hr) Kristalni oblici eravaciklina